Your browser doesn't support javascript.
loading
Activity of everolimus (RAD001) in relapsed and/or refractory multiple myeloma: a phase I study.
Günther, Andreas; Baumann, Philipp; Burger, Renate; Kellner, Christian; Klapper, Wolfram; Schmidmaier, Ralf; Gramatzki, Martin.
Afiliación
  • Günther A; Division of Stem Cell Transplantation and Immunotherapy, 2 Department of Medicine, University of Kiel, Germany a.guenther@med2.uni-kiel.de.
  • Baumann P; Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig-Maximillians-Universität München (LMU), Germany.
  • Burger R; Division of Stem Cell Transplantation and Immunotherapy, 2 Department of Medicine, University of Kiel, Germany.
  • Kellner C; Division of Stem Cell Transplantation and Immunotherapy, 2 Department of Medicine, University of Kiel, Germany.
  • Klapper W; Division of Hematopathology, Institute of Pathology, University of Kiel, Germany.
  • Schmidmaier R; Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig-Maximillians-Universität München (LMU), Germany.
  • Gramatzki M; Division of Stem Cell Transplantation and Immunotherapy, 2 Department of Medicine, University of Kiel, Germany.
Haematologica ; 100(4): 541-7, 2015 Apr.
Article en En | MEDLINE | ID: mdl-25682600

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sirolimus / Inmunosupresores / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2015 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sirolimus / Inmunosupresores / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2015 Tipo del documento: Article País de afiliación: Alemania
...